The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

From FDA approvals streamlining access to critical therapies to new breakthroughs in challenging malignancies, the field of cancer care continues to demonstrate remarkable progress.

FDA updates CAR T-cell therapy labels, easing monitoring requirements and expanding access for eligible patients in oncology.

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

FDA issues a complete response letter for oxylanthanum carbonate, a treatment for hyperphosphatemia in patients with chronic ...

Obsessive-compulsive disorder (OCD) impacts approximately 2% of the global population, often preventing individuals from living life to their full potential. Optibrium, a leading developer of ...